PPI
FREE subscriptions for doctors and students... click here
You have 3 more open access pages.
Proton pump inhibitors (PPIs) such as omeprazole and lansoprazole inhibit the production of gastric acid.
They are the drugs of choice for patients with significant erosive oesophagitis and for patients with Zollinger- Ellinson syndrome.
The NICE guideline concerning the management of dyspepsia in primary care suggests PPIs as first-line therapies in non-ulcer dyspepsia, gastro-oesophageal reflux disease and peptic ulcer disease (see linked NICE dyspepsia guideline).
Last reviewed 07/2021
Links:
- indications
- mode of action
- contra-indications
- toxicity and drug interactions
- complications
- proton pump inhibitors in the treatment of dyspepsia
- proton pump inhibitors Vs H2 antagonists in oesophagitis
- NICE guidance - management of dyspepsia in adults in primary care (summary section)
- NSAID and age when should use a PPI
- PPI and glycaemic control